| Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data HA Miller, X Yin, SA Smith, X Hu, X Zhang, J Yan, DM Miller, ... Lung cancer 156, 20-30, 2021 | 36 | 2021 |
| Evaluation of drug-loaded gold nanoparticle cytotoxicity as a function of tumor vasculature-induced tissue heterogeneity HA Miller, HB Frieboes Annals of biomedical engineering 47, 257-271, 2019 | 21 | 2019 |
| Computational/experimental evaluation of liver metastasis post hepatic injury: interactions with macrophages and transitional ecm SV Hudson, HA Miller, GE Mahlbacher, D Saforo, LJ Beverly, GE Arteel, ... Scientific reports 9 (1), 15077, 2019 | 13 | 2019 |
| Pharmacokinetic/pharmacodynamics modeling of drug-loaded PLGA nanoparticles targeting heterogeneously vascularized tumor tissue HA Miller, HB Frieboes Pharmaceutical research 36, 1-15, 2019 | 12 | 2019 |
| Lung cancer survival prediction and biomarker identification with an ensemble machine learning analysis of tumor core biopsy metabolomic data HA Miller, VH van Berkel, HB Frieboes Metabolomics 18 (8), 57, 2022 | 11 | 2022 |
| CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting K Shawn LyBarger, HA Miller, HB Frieboes Scientific Reports 12 (1), 19783, 2022 | 9 | 2022 |
| Modeling of tumor growth with input from patient-specific metabolomic data HA Miller, J Lowengrub, HB Frieboes Annals of biomedical engineering 50 (3), 314-329, 2022 | 9 | 2022 |
| Multicellular ovarian cancer model for evaluation of nanovector delivery in ascites and metastatic environments SJ Winter, HA Miller, JM Steinbach-Rankins Pharmaceutics 13 (11), 1891, 2021 | 8 | 2021 |
| Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases LB Sims, HA Miller, ME Halwes, JM Steinbach-Rankins, HB Frieboes European Journal of Pharmaceutics and Biopharmaceutics 138, 37-47, 2019 | 7 | 2019 |
| Metabolomic differentiation of tumor core versus edge in glioma ME Baxter, HA Miller, J Chen, BJ Williams, HB Frieboes Neurosurgical Focus 54 (6), E4, 2023 | 5 | 2023 |
| Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival HA Miller, SN Rai, X Yin, X Zhang, JA Chesney, VH van Berkel, ... Metabolomics 18 (5), 31, 2022 | 4 | 2022 |
| Discrepancies in metabolomic biomarker identification from patient-derived lung cancer revealed by combined variation in data pre-treatment and imputation methods HA Miller, R Emam, CM Lynch, S Bockhorst, HB Frieboes Metabolomics 17, 1-13, 2021 | 4 | 2021 |
| Evaluation of stacked ensemble model performance to predict clinical outcomes: a COVID-19 study R Kablan, HA Miller, S Suliman, HB Frieboes International Journal of Medical Informatics 175, 105090, 2023 | 3 | 2023 |
| Evaluation of Lung Cancer Patient Response to First-Line Chemotherapy by Integration of Tumor Core Biopsy Metabolomics with Multiscale Modeling HA Miller, DM Miller, VH van Berkel, HB Frieboes Annals of Biomedical Engineering 51 (4), 820-832, 2023 | 3 | 2023 |
| Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath MJ Taylor, CP Chitwood, Z Xie, HA Miller, VH van Berkel, XA Fu, ... Respiratory Medicine 222, 107534, 2024 | 2 | 2024 |
| Prediction of lung cancer immunotherapy response via machine learning analysis of immune cell lineage and surface markers AN Mueller, S Morrisey, HA Miller, X Hu, R Kumar, PT Ngo, J Yan, ... Cancer Biomarkers 34 (4), 681-692, 2022 | 2 | 2022 |
| Anti-tumor effect of pH-sensitive drug-loaded nanoparticles optimized via an integrated computational/experimental approach HA Miller, Y Zhang, BR Smith, HB Frieboes Nanoscale 16 (4), 1999-2011, 2024 | 1 | 2024 |
| Pulmonary Fibrosis Diagnosis and Disease Progression Detected Via Hair Metabolome Analysis HA Miller, S Suliman, HB Frieboes Lung, 1-13, 2024 | | 2024 |
| Prediction of Disease Type and Severity in Interstitial Lung Disease Via Machine Learning Analysis of Exhaled Volatile Organic Compounds SA Suliman, M Taylor, H Miller, H Frieboes A13. TOWARDS IMPLEMENTATION: NEW BIOMARKERS IN ILD, A1005-A1005, 2024 | | 2024 |
| Metabolomic Differentiation of Tumor Core vs. Edge in Glioma Via Machine Learning BJ Williams, H Frieboes, M Baxter, H Miller, J Chen Neurosurgery 70 (Supplement_1), 210, 2024 | | 2024 |
Hermann FrieboesProfessor, Dept. of Bioengineering, University of Louisville在 louisville.edu 的电子邮件经过验证
